# LOPINAVIR; RITONAVIR
> **ANDA091202** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMA · Approved 2011-06-08
## Drug
- **FDA Application Number:** ANDA091202
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LOPINAVIR; RITONAVIR
- **Generic name:** Lopinavir
- **Active ingredients:** LOPINAVIR; RITONAVIR
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MYLAN PHARMA
- **First approval:** 2011-06-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091202)
---
*AI Analytics · CC0 1.0*